JP2009544758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009544758A5 JP2009544758A5 JP2009522956A JP2009522956A JP2009544758A5 JP 2009544758 A5 JP2009544758 A5 JP 2009544758A5 JP 2009522956 A JP2009522956 A JP 2009522956A JP 2009522956 A JP2009522956 A JP 2009522956A JP 2009544758 A5 JP2009544758 A5 JP 2009544758A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- disease
- salt
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 10
- -1 N-((1R, 2S, 5R) -5- (isopropyl (methyl) amino) -2-((S) -2-oxo-3- (6- (trifluoromethyl) quinazolin-4-ylamino) pyrrolidine- 1-yl) cyclohexyl) acetamide compound Chemical class 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 239000013078 crystal Substances 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 201000001320 Atherosclerosis Diseases 0.000 claims 3
- 208000011231 Crohn disease Diseases 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 206010020718 hyperplasia Diseases 0.000 claims 3
- 201000006417 multiple sclerosis Diseases 0.000 claims 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 3
- 238000000634 powder X-ray diffraction Methods 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 238000002054 transplantation Methods 0.000 claims 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 2
- 206010018364 Glomerulonephritis Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 150000002466 imines Chemical class 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 210000000056 organ Anatomy 0.000 claims 2
- 229910052697 platinum Inorganic materials 0.000 claims 2
- 208000037803 restenosis Diseases 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- 206010065040 AIDS dementia complex Diseases 0.000 claims 1
- 206010001889 Alveolitis Diseases 0.000 claims 1
- 206010002329 Aneurysm Diseases 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- 206010019196 Head injury Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010048858 Ischaemic cardiomyopathy Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010037660 Pyrexia Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 206010047115 Vasculitis Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 125000006242 amine protecting group Chemical group 0.000 claims 1
- 239000000010 aprotic solvent Substances 0.000 claims 1
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 239000012024 dehydrating agents Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 201000001155 extrinsic allergic alveolitis Diseases 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 208000022098 hypersensitivity pneumonitis Diseases 0.000 claims 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 230000003589 nefrotoxic effect Effects 0.000 claims 1
- 201000008383 nephritis Diseases 0.000 claims 1
- 231100000381 nephrotoxic Toxicity 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000006268 reductive amination reaction Methods 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 0 CCOC([C@](CC(CC1)N(C)C(C)C)C1N(CC[C@@]1*)C1=O)=O Chemical compound CCOC([C@](CC(CC1)N(C)C(C)C)C1N(CC[C@@]1*)C1=O)=O 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83423506P | 2006-07-28 | 2006-07-28 | |
| US89602607P | 2007-03-21 | 2007-03-21 | |
| US11/782,704 US7671062B2 (en) | 2006-07-28 | 2007-07-25 | Modulators of chemokine receptor activity, crystalline forms and process |
| PCT/US2007/074438 WO2008014381A2 (en) | 2006-07-28 | 2007-07-26 | Modulators of chemokine receptor activity, crystalline forms and process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009544758A JP2009544758A (ja) | 2009-12-17 |
| JP2009544758A5 true JP2009544758A5 (cg-RX-API-DMAC7.html) | 2010-08-12 |
Family
ID=38823540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009522956A Withdrawn JP2009544758A (ja) | 2006-07-28 | 2007-07-26 | ケモカイン受容体活性のモジュレーター、結晶形および方法 |
Country Status (29)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7687508B2 (en) * | 2006-07-28 | 2010-03-30 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| US8383812B2 (en) * | 2009-10-13 | 2013-02-26 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| MA42133A (fr) * | 2015-05-21 | 2021-06-02 | Chemocentryx Inc | Modulateurs du ccr2 |
| DK3655395T3 (da) * | 2017-07-20 | 2022-03-07 | Bristol Myers Squibb Co | Fremgangsmåde til fremstilling af n-((1r,2s,sr)-5-(tert-butylamino)-2-((s)-3-(7- tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1- yl)cyclohexyl)acetamid |
| CA3075638A1 (en) | 2017-09-25 | 2019-03-28 | Chemocentryx, Inc. | Combination therapy using a chemokine receptor 2 (ccr2) antagonist and a pd-1/pd-l1 inhibitor |
| US20190269664A1 (en) | 2018-01-08 | 2019-09-05 | Chemocentryx, Inc. | Methods of treating solid tumors with ccr2 antagonists |
| ES2991280T3 (es) | 2018-01-08 | 2024-12-03 | Chemocentryx Inc | Antagonistas de CCR2 para el tratamiento del linfoma cutáneo de linfocitos T |
| CN115494184B (zh) * | 2022-05-09 | 2023-07-28 | 浙江海正药业股份有限公司 | 一种同时检测药物中异丙苯磺酸甲酯、异丙苯磺酸乙酯的方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6383082A (ja) | 1986-09-26 | 1988-04-13 | Takeda Chem Ind Ltd | テトラヒドロフランカルボン酸誘導体の製造法 |
| EP0550924A1 (en) | 1991-12-16 | 1993-07-14 | Merck & Co. Inc. | 2-Pyrrolidinone derivatives as HIV protease inhibitors |
| GB9515411D0 (en) | 1995-07-27 | 1995-09-27 | Pharmacia Spa | N-(4-substituted-benzyl)-2-aminolactam derivatives |
| US5827875A (en) | 1996-05-10 | 1998-10-27 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
| UA51716C2 (uk) | 1996-07-08 | 2002-12-16 | Авентіс Фармасьютікалз Продактс Інк. | Сполуки, що мають гіпотензивну, кардіопротекторну, анти-ішемічну та антиліполітичну властивості, фармацевтична композиція та способи лікування |
| US6054579A (en) | 1997-06-26 | 2000-04-25 | Leukosite, Inc. | Synthesis of substituted lactams |
| GB9716656D0 (en) | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
| KR20010034442A (ko) | 1998-01-27 | 2001-04-25 | 아벤티스 파마슈티칼즈 프로덕츠 인코포레이티드 | 치환된 옥소아자헤테로사이클릴 인자 Ｘａ 억제제 |
| PL342254A1 (en) | 1998-01-29 | 2001-06-04 | Aventis Pharm Prod Inc | Method of obtaining n-[(aliphatic or aromatic substituend)carbonyl)]-2-aminacetamide and cyclised compound |
| US6492553B1 (en) | 1998-01-29 | 2002-12-10 | Aventis Pharamaceuticals Inc. | Methods for preparing N-[(aliphatic or aromatic)carbonyl)]-2-aminoaetamide compounds and for cyclizing such compounds |
| GB9803228D0 (en) | 1998-02-17 | 1998-04-08 | Zeneca Ltd | Chemical compounds |
| US6541208B1 (en) | 1998-03-17 | 2003-04-01 | University Of Maryland Biotechnology Institute | Diagnostic method for distinguishing HIV-associated dementia from other forms of dementia |
| WO2001017992A1 (en) | 1999-09-09 | 2001-03-15 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
| US6620823B2 (en) | 2000-07-11 | 2003-09-16 | Bristol-Myers Squibb Pharme Company | Lactam metalloprotease inhibitors |
| US6706712B2 (en) * | 2000-12-20 | 2004-03-16 | Bristol-Myers Squibb Pharma Company | Cyclic derivatives as modulators of chemokine receptor activity |
| US6974836B2 (en) * | 2000-12-20 | 2005-12-13 | Bristol-Myers Squibb Pharma Company | Diamines as modulators of chemokine receptor activity |
| ATE318596T1 (de) | 2001-03-29 | 2006-03-15 | Topotarget As | Succinimid- und maleimidderivate und ihre verwendung als katalytische inhibitoren der topoisomerase ii |
| GB0114867D0 (en) | 2001-06-18 | 2001-08-08 | Merck Sharp & Dohme | Therapeutic agents |
| DE10135043A1 (de) * | 2001-07-11 | 2003-01-30 | Bayer Cropscience Gmbh | Substituierte 3-Heteroaryl(amino- oder oxy)-pyrrolidin-2-one, Verfahren zu deren Herstellung und Verwendung als Herbizide oder als Pflanzenwachstumsregulatoren |
| US7087604B2 (en) * | 2002-03-08 | 2006-08-08 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| TW200307667A (en) * | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| WO2004022536A1 (en) | 2002-09-04 | 2004-03-18 | Glenmark Pharmaceuticals Limited | New heterocyclic amide compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| TW200508224A (en) * | 2003-02-12 | 2005-03-01 | Bristol Myers Squibb Co | Cyclic derivatives as modulators of chemokine receptor activity |
| US7338975B2 (en) * | 2003-02-12 | 2008-03-04 | Bristol-Myers Squibb Co. | Lactams as modulators of chemokine receptor activity |
| US7291615B2 (en) | 2003-05-01 | 2007-11-06 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| US7230133B2 (en) * | 2003-05-01 | 2007-06-12 | Bristol-Myers Squibb Company | Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| US20060205761A1 (en) | 2003-06-06 | 2006-09-14 | Catherine Abbadie | Ccr-2 antagonists for treatment of neuropathic pain |
| US20050043392A1 (en) * | 2003-08-21 | 2005-02-24 | Carter Percy H. | Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| US7863317B2 (en) * | 2003-08-21 | 2011-01-04 | Bristol-Myers Squibb Company | Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| US7378409B2 (en) * | 2003-08-21 | 2008-05-27 | Bristol-Myers Squibb Company | Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| US7317019B2 (en) * | 2003-08-21 | 2008-01-08 | Bristol Myers Squibb Co. | N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| US7163937B2 (en) | 2003-08-21 | 2007-01-16 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| CN101005855A (zh) | 2004-07-30 | 2007-07-25 | 辉瑞产品公司 | 治疗由ccr2介导的疾病或紊乱的方法 |
| MX2007003793A (es) * | 2004-09-28 | 2007-07-11 | Johnson & Johnson | Antagonistas del receptor 2 de citocina quimioatrayente de dipiperidina sustituida. |
-
2007
- 2007-07-25 US US11/782,704 patent/US7671062B2/en active Active
- 2007-07-26 PT PT07799831T patent/PT2049477E/pt unknown
- 2007-07-26 MX MX2009000803A patent/MX2009000803A/es active IP Right Grant
- 2007-07-26 EP EP10001344A patent/EP2184283A1/en not_active Withdrawn
- 2007-07-26 SI SI200730305T patent/SI2049477T1/sl unknown
- 2007-07-26 WO PCT/US2007/074438 patent/WO2008014381A2/en not_active Ceased
- 2007-07-26 SG SG201000704-5A patent/SG158925A1/en unknown
- 2007-07-26 CL CL200702194A patent/CL2007002194A1/es unknown
- 2007-07-26 ES ES07799831T patent/ES2346591T3/es active Active
- 2007-07-26 TW TW096127306A patent/TW200823203A/zh unknown
- 2007-07-26 NZ NZ574656A patent/NZ574656A/en not_active IP Right Cessation
- 2007-07-26 CA CA002659259A patent/CA2659259A1/en not_active Abandoned
- 2007-07-26 EA EA200900244A patent/EA014960B1/ru not_active IP Right Cessation
- 2007-07-26 AT AT07799831T patent/ATE471928T1/de active
- 2007-07-26 PL PL07799831T patent/PL2049477T3/pl unknown
- 2007-07-26 KR KR1020097004327A patent/KR20090035036A/ko not_active Withdrawn
- 2007-07-26 AR ARP070103321A patent/AR062114A1/es not_active Application Discontinuation
- 2007-07-26 DE DE602007007335T patent/DE602007007335D1/de active Active
- 2007-07-26 BR BRPI0715066-0A patent/BRPI0715066A2/pt not_active IP Right Cessation
- 2007-07-26 JP JP2009522956A patent/JP2009544758A/ja not_active Withdrawn
- 2007-07-26 CN CNA2007800327628A patent/CN101511822A/zh active Pending
- 2007-07-26 PE PE2007000968A patent/PE20080838A1/es not_active Application Discontinuation
- 2007-07-26 DK DK07799831.8T patent/DK2049477T3/da active
- 2007-07-26 EP EP07799831A patent/EP2049477B1/en active Active
- 2007-07-26 AU AU2007279256A patent/AU2007279256A1/en not_active Abandoned
- 2007-07-26 CL CL200702195A patent/CL2007002195A1/es unknown
- 2007-07-26 HR HR20100371T patent/HRP20100371T1/hr unknown
- 2007-07-26 CL CL200702196A patent/CL2007002196A1/es unknown
-
2009
- 2009-01-15 IL IL196518A patent/IL196518A0/en unknown
- 2009-01-16 NO NO20090256A patent/NO20090256L/no not_active Application Discontinuation
- 2009-01-27 CO CO09007271A patent/CO6190527A2/es not_active Application Discontinuation
-
2010
- 2010-09-22 CY CY20101100852T patent/CY1110785T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009544758A5 (cg-RX-API-DMAC7.html) | ||
| JP6966590B2 (ja) | オメカムチブメカルビルの塩及び塩を調製するプロセス | |
| NL1026438C2 (nl) | Nieuwe verbindingen. | |
| JP2009544756A5 (cg-RX-API-DMAC7.html) | ||
| JP5273587B2 (ja) | キナゾリンジオン骨格を有するフェニルアラニン誘導体の製造方法及び製造中間体 | |
| TW201720825A (zh) | 二氫吡啶並環化合物的晶型、製備方法和中間體 | |
| JP2005503386A5 (cg-RX-API-DMAC7.html) | ||
| JP2013532164A (ja) | トロンビン特異的インヒビターを調製する方法 | |
| JP2009508949A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2014017515A1 (ja) | ４−［５−（ピリジン−４−イル）−１ｈ−１，２，４−トリアゾール−３−イル］ピリジン−２−カルボニトリルの結晶多形およびその製造方法 | |
| CA2660320A1 (en) | Morpholinyl and pyrrolidinyl analogs | |
| CN104884427B (zh) | 可用于合成苯甲酰胺化合物的化合物 | |
| HRP20140072T1 (hr) | N-((1r,2s,5r)-5-(terc-butilamino)-2-((s)-3-(7-terc-butilpirazolo[1,5-a][1,3,5]triazin-4-ilamino)-2-oksopirolidin-1-il)cikliheksil)acetamid, dvostruki modulator aktivnosti receptora za hemokin, kristalni oblici i postupci | |
| JP2024503855A (ja) | アミノピリミジン系ｆａｋ阻害剤化合物を合成する方法 | |
| AU2012229859B2 (en) | Nitrogen-containing saturated heterocyclic compound | |
| HRP20100371T1 (hr) | Modulatori aktivnosti kemokinskih receptora, kristalni oblici i postupci | |
| HRP20110465T1 (hr) | Modulatori aktivnosti receptora kemokina, kristalni oblici i postupak | |
| CN107810189B (zh) | 用于制备氮芥衍生物的方法 | |
| CN116947763A (zh) | 2-巯基-5-氰基-6-芳基嘧啶杂环类化合物、制备方法和应用 | |
| WO2018233727A1 (zh) | 一种吲哚类化合物及其应用，一种药物组合物及其应用 | |
| KR20100017565A (ko) | (ｒ)-2-메틸피롤리딘 및 (ｓ)-2-메틸피롤리딘 및 이의 타르트레이트 염의 제조 방법 | |
| KR20180044384A (ko) | Ror 감마 조절인자로서 신규의 카보사이클릭 화합물 | |
| CN101611024A (zh) | 芳基-取代的吡唑-酰胺化合物的晶形 | |
| JP2008540538A5 (cg-RX-API-DMAC7.html) | ||
| CN107531654A (zh) | 制备二羧酸化合物的方法 |